“Mean Percentage Improvement in Psoriasis Area and Severity Index (PASI) Response and Absolute PASI Through 5 Years of Continuous Treatment With Guselkumab (GUS) in VOYAGE 1 ”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): s3. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/1519.